Deoxyribonucleic Acid Trip
By Gina Maranto,
New York Times
| 08. 28. 2002
Book review of Gregory Stock,
Redesigning Humans: Our Inevitable
Genetic Future.
GREGORY STOCK has written an enthusiastic book in support of
germ-line manipulations -- that is, making genetic modifications
to eggs, sperm and embryos that can be passed on to future generations.
Like previous explorations of the subject by the ethicist Joseph
F. Fletcher, the lawyer John Robertson and the biologist James
Watson, among others, ''Redesigning Humans: Our Inevitable Genetic
Future'' serves as an apologia for those scientists and physicians
who are already edging toward such work in a piecemeal fashion
in research labs and in vitro fertilization clinics around the
world. It advocates the wholesale adoption of genetic manipulations
with the purpose of finally taking control of human evolution.
This, the author writes, ''is the ultimate expression and realization
of our humanity.''
Because of the breadth of his scientific knowledge and his
considerable flair as a writer, Stock -- who heads the program
on medicine, technology and society at the School of Medicine
of the University of California, Los Angeles -- is a forceful
advocate. First and foremost...
Related Articles
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Emily Baumgaetner Nunn, The New York Times | 07.20.2026
The National Institutes of Health recently announced a remarkable achievement: the world’s largest database of human genomes, a repository of information that the agency says will help usher in a new era in personalized medicine.
Scientists are already developing clinical...
By Risa Cromer, The Conversation | 07.17.2026